Upload Avatar (500 x 500)
Ling Yu
scaling@whu.edu.cn
English, Chinese
Hubei
Wuhan University
Medical School
  • 2004.09-2009.06 Bachelor of Clinical Medicine from Wuhan University
  • 2012.08-2013.08 Visiting PhD student at the University of Manchester
  • 2009.09-2014.06 PhD in Surgery from Wuhan University
  • Received a grant from the National Natural Science Foundation of China
  • Participated in 5 provincial research projects
  • Published a monograph on osteosarcoma
  • 2014.07-2014.12 Resident Physician at Renmin Hospital of Wuhan University
  • 2014.12-2018.12 Attending Physician at Renmin Hospital of Wuhan University
  • 2018.12-present Associate Chief Physician at Renmin Hospital of Wuhan University
  • 2018.04-2019.04 Vice President at Xianfeng County People's Hospital
  • 2020.12-present Vice President at Shayang County People's Hospital
  • 2015, 2017, 2018 Advanced Worker of Renmin Hospital of Wuhan University
  • 2019 Advanced Individual in Safety Work at Renmin Hospital of Wuhan University
  • 2020 People's Anti-Epidemic Model at Renmin Hospital of Wuhan University
Spinal Surgery
Bone Tumor
  • Artificial cervical disc replacement vs. anterior cervical decompression and fusion for the treatment of cervical spondylotic myelopathy, Yu, Ling; Sun, Xiangran; Hu, Qingzhu; Guo, Weichun*, 2019
  • Phase I decompression surgery for cervical spinal stenosis combined with lumbar spinal stenosis, Yu, Ling; Sun, Xiangran; Hu, Qingzhu; Guo, Weichun*, 2018
  • miR-429 targets Sox2 to suppress the stem cell-like properties of osteosarcoma, Yu, Ling; Zhang, Zhengpei; Sun, Xiangran; Zheng, Di; Guo, Weichun*, 2017
  • Doxorubicin activates the Notch signaling pathway to promote the stemness of osteosarcoma cells, Yu, Ling; Zhang, Zhengpei; Tao, Chunjie; Guo, Weichun*; Gao, Tian; Fang, Zhiwei; Fan, Zhengfu*, 2017
  • Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells, Zhang, Zhengpei; Yu, Ling*; Dai, Guo; Xia, Kezhou; Liu, Gaiwei; Song, Qi; Tao, Chunjie; Gao, Tian; Guo, Weichun*, 2017
  • The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo, Dai, Guo; Yu, Ling; Yang, Jian; Xia, Kezhou; Zhang, Zhengpei; Liu, Gaiwei; Gao, Tian; Guo, Weichun*, 2017
  • Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling, Cao, Yongfei; Yu, Ling; Dai, Guo; Zhang, Shanshan; Zhang, Zhengpei; Gao, Tian; Guo, Weichun*, 2017
  • An injectable bioactive magnesium phosphate cement incorporating carboxymethyl chitosan for bone regeneration, Yu, Ling; Xia, Kezhou; Gong, Changtian; Chen, Jingteng; Li, Wei; Zhao, Yanan; Guo, Weichun*; Dai, Honglian*, 2020
  • The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling, Yu, Ling; Xia, Kezhou; Gao, Tian; Chen, Jingteng; Zhang, Zhengpei; Sun, Xiangran; Simoes, Bruno M.; Eyre, Rachel; Fan, Zhengfu; Guo, Weichun*; Clarke, Robert B*, 2019
  • Chitosan oligosaccharides protect nucleus pulposus cells from hydrogen peroxide-induced apoptosis in a rat experimental model, Jia, Peng; Yu, Ling; Tao, Chunjie; Dai, Guo; Zhang, Zhengpei; Liu, Shiqing*, 2017
  • miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1, Guo, Xiaodong; Yu, Ling; Zhang, Zhengpei; Dai, Guo; Gao, Tian; Guo, Weichun*, 2017
  • Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway, Ji, Peng; Yu, Ling; Guo, Wei-Chun; Mei, Hong-Jun; Wang, Xiao-Ju; Chen, Hu; Fang, Shuo; Yang, Jian, 2015
  • Cisplatin selects for stem-like cells in osteosarcoma by activating notch signaling, Yu, Ling; Fan, Zhengfu; Fang, Shuo; Yang, Jian; Gao, Tian; Simoes, Bruno M.; Eyre, Rachel; Guo, Weichun*; Clarke, Robert B*, 2016
  • KIF18B promotes tumor progression in osteosarcoma by activating beta-catenin, Gao, Tian; Yu, Ling; Fang, Zhiwei; Lu, Jiayong; Bai, Chujie; Li, Shu; Xue, Ruifeng; Zhang, Lu; Tan, Zhichao; Fan, Zhengfu*, 2020
Spine Surgery Orthopedics Bone Tumor Osteosarcoma Treatment Research Clinical Oncology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.